CEREFOLIN NAC Rx
Generic Name and Formulations:
L-methylfolate calcium (Metafolin) 6mg, Algae-S powder 90.314mg, methylcobalamin 2mg, N-acetylcysteine 600mg; caplets.
Alfasigma USA, Inc.
Indications for CEREFOLIN NAC:
Clinical dietary management of mild cognitive impairment.
Use only under medical supervision. 1 caplet daily.
Avoid if renal stones occur. Do not administer to critically ill patients. Folic acid may mask Vit.B12 deficiency, including pernicious anemia. History of peptic ulcer. Chronic liver disease. Pre-term newborns. Nursing mothers: not recommended.
Concomitant nitrates: increased risk of headaches. Capecitabine toxicity increased with addition of leucovorin. May produce false-positive result in nitroprusside test for ketone bodies.
Allergic reactions, mild transient diarrhea, itching, transitory exanthema, feeling body swelling, nausea, vomiting, rash, flushing, epigastric pain, constipation, headache; rare: renal stones.
Endocrinology Advisor Articles
- Higher BUN May Increase Risk for Incident Diabetes
- Efficacy of Novel GLP-1 Receptor Agonist Drug Device Examined
- Takeout Food May Increase Adverse Health Consequences in Children
- Nonhormonal Options Available for Menopause Symptom Relief
- Plasma Volume Changes Mediate Risk of CV Mortality With Empagliflozin
- New Consensus Recommendations on Use of Continuous Glucose Monitoring
- Does Genetic Susceptibility Lead to Late-Onset Type 1 Diabetes?
- Clinical Outcomes in T2D: Low-Carbohydrate vs Calorie-Restricted Diet
- New Continuous Glucose Monitoring System Now Available for Medicare Patients
- Text Message-Delivered Interventions Effective for Weight Management
- Effect of Intra-Articular Depot Betamethasone on Insulin Resistance in T2D
- Gastric Bypass vs Sleeve Gastrectomy Outcomes in Morbid Obesity
- Acute Kidney Injury Increases Risk for Postdischarge Hypoglycemia in Diabetes
- Novel Deep Learning System May Help Identify Diabetic Retinopathy
- Trends in CVD, Risk Factors, and Medications in Children With T1D